Taken together, current RCT and PRO data suggest that GLP-1RA treatment is associated with changes in eating experience, but remain insufficient to determine the specific functional level involved (sensory, liking, or wanting) or the long-term clinical significance of these changes
Adding GIP enhances fat metabolism and improves insulin sensitivity, which is why tirzepatide outperforms semaglutide on weight loss
Lately, Ive been getting a lot of questions about NAD+what it is, what it does, and whether its worth trying in IV therapy
: DCGI approval strengthens Sun Pharmas specialty portfolio
demonstrated cumulative effects after multiple CJC-1295 DAC doses, with IGF-1 remaining above baseline for up to 28 days (PMID: 16352683)
Metabolic reprogramming and epigenetic modifications on the path to cancer